Enliven Therapeutics Inc.
ELVN | NASDAQ
$47.97
-$0.90 (-1.84%)
Sep 22, 2026, 1:07 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -32.49M | -23.63M | -29.67M | -20.15M | -25.34M | -28.54M | -23.18M | -23.16M | -19.95M | -22.74M | -19.37M | -20.77M | -16.72M | -14.72M | -9.55M | -10.55M | -8.89M | -8.67M | -14.32M | -13.65M | -13.16M | -10.26M |
Depreciation & Amortization | 518K | 280K | 101K | 62K | 154K | 74K | 80K | 80K | 78K | 79K | 77K | 78K | 74K | 67K | 64K | 60K | 52K | 39K | 25K | 24K | 25K | 25K |
Stock-Based Compensation | 13.92M | 7.4M | 12.31M | 7.19M | 7.72M | 6.8M | 5.34M | 5.18M | 5.14M | 4.52M | 3.06M | 3.4M | 4.2M | 2.26M | 735K | 1.1M | 701K | 654K | n/a | n/a | n/a | n/a |
Other Working Capital | -2.02M | -2.92M | 391K | 863K | -476K | -2.72M | -833K | 5.05M | -2.78M | -6.79M | 6.43M | 4.75M | 1.42M | -8.94M | 588K | -153K | 420K | -828K | 895K | 1.85M | 2.2M | -4.82M |
Other Non-Cash Items | 3.56M | 93K | 198K | -221K | 87K | 40K | 1.07M | 719K | -1.32M | -582K | 2.46M | -1.76M | -831K | n/a | n/a | 1.74M | n/a | n/a | 1.03M | 1.02M | 948K | 1M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -4.04M | -3.43M | 1.22M | -157K | 313K | -2.5M | -510K | 4.99M | -4.38M | -4.64M | 5.46M | 3.15M | 1.23M | -8.45M | 606K | 1.21M | 1.01M | -2.39M | 779K | 1.7M | 1.82M | -3.79M |
Operating Cash Flow | -18.53M | -19.29M | -15.84M | -13.28M | -17.06M | -24.13M | -17.2M | -12.19M | -20.44M | -23.36M | -12.48M | -15.89M | -12.05M | -20.84M | -8.15M | -6.45M | -7.12M | -10.36M | -12.49M | -10.9M | -10.37M | -13.02M |
Capital Expenditures | -99K | n/a | n/a | 1K | -139K | -20K | n/a | -22K | -2K | -20K | -14K | -16K | -88K | -31K | -101K | -14K | -303K | -194K | n/a | n/a | n/a | -12K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -40M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -560.16M | -65.84M | -75.52M | -71.86M | -240.19M | -59.23M | -116.52M | -234.23M | -120.83M | -56.78M | -41.3M | -75.53M | -151.43M | n/a | n/a | n/a | n/a | n/a | -17.79M | -22.23M | -3.81M | -3.72M |
Sales Maturities Of Investments | 118.69M | 108.36M | 87.69M | 67.8M | 56.74M | 60.67M | 117.24M | 196.67M | 77.17M | 38.91M | 80M | 40M | n/a | n/a | n/a | n/a | n/a | n/a | 3.3M | 13.4M | 7.2M | 22.04M |
Other Investing Acitivies | n/a | n/a | 213K | n/a | n/a | n/a | n/a | 52.4M | 10M | n/a | n/a | 40M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -441.57M | 42.53M | 12.38M | -4.06M | -183.59M | 1.43M | 727K | 14.83M | -33.67M | -17.89M | 38.69M | -35.55M | -151.52M | -31K | -101K | -14K | -303K | -194K | -14.49M | -8.83M | 3.39M | 18.3M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -10.05M | n/a | n/a | n/a | n/a | n/a | 90.48M | n/a | n/a | 270K | n/a | n/a | -1.32M | 74.4M | -2.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 463.42M | 10.05M | 623K | -368K | 218.38M | 234K | 39.97M | 1.12M | 1.81M | 90.27M | 90K | -425K | -2.82M | 237.44M | -2.38M | 164K | 5K | 409K | -10K | 46.99M | 1.66M | 460K |
Net Cash Flow | 3.32M | 33.29M | -2.84M | -17.71M | 17.73M | -22.47M | 23.5M | 3.75M | -52.29M | 49.02M | 26.35M | -51.87M | -166.39M | 203.9M | -10.62M | 19.06M | -6.05M | -11.83M | -26.99M | 27.26M | -5.4M | 5.74M |
Free Cash Flow | -18.63M | -19.29M | -15.84M | -13.28M | -17.2M | -24.15M | -17.2M | -12.22M | -20.44M | -23.38M | -12.5M | -15.91M | -12.14M | -20.88M | -8.25M | -6.46M | -7.43M | -10.56M | -12.49M | -10.9M | -10.37M | -13.03M |
Adj. Free Cash Flow | -32.55M | -26.69M | -28.15M | -20.46M | -24.92M | -30.95M | -22.54M | -17.39M | -25.58M | -27.9M | -15.55M | -19.31M | -16.33M | -23.14M | -8.98M | -7.56M | -8.13M | -11.21M | -12.49M | -10.9M | -10.37M | -13.03M |
Maintenance CapEx | -99K | n/a | n/a | -1K | -139K | -20K | n/a | -22K | -2K | -20K | -14K | -16K | -74K | -31K | -64K | -14K | -52K | -39K | n/a | n/a | n/a | -12K |
Growth CapEx | n/a | n/a | n/a | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14K | n/a | -37K | n/a | -251K | -155K | n/a | n/a | n/a | n/a |
Owner Earnings | -18.63M | -19.29M | -15.84M | -13.28M | -17.2M | -24.15M | -17.2M | -12.22M | -20.44M | -23.38M | -12.5M | -15.91M | -12.12M | -20.88M | -8.21M | -6.46M | -7.18M | -10.4M | -12.49M | -10.9M | -10.37M | -13.03M |
Add to Watchlist
Select watchlists to add or remove ELVN